Nesiritide - Not verified [3] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 14, 2005, Pages 1525-1527

  Sackner Bernstein, Jonathan ^a   Aaronson, Keith D ^b   Schreiner, George ^c   Topol, Eric J ^d  

^a University of Michigan ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SCIOS INC   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; NESIRITIDE; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; NATRIURETIC FACTOR; VASODILATOR AGENT; ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

CLINICAL PRACTICE; CLINICAL TRIAL; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; CONGESTIVE HEART FAILURE; EVIDENCE BASED MEDICINE; NOTE; DRUG APPROVAL; UNITED STATES; ECONOMICS; HEALTH SERVICE; INTRAVENOUS DRUG ADMINISTRATION; REIMBURSEMENT; RHEUMATOID ARTHRITIS;

DIURETICS; DYSPNEA; EVIDENCE-BASED MEDICINE; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; VASODILATOR AGENTS; DRUG APPROVAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HEALTH SERVICES MISUSE; INFUSIONS, INTRAVENOUS; INSURANCE, HEALTH, REIMBURSEMENT;

EID: 25844528859     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc052142     Document Type: Letter

References (0)